AeroLeads people directory · profile
Kelly M. Mcvearry Email & Phone Number
Chief Executive Officer
at
BENTO BIOLOGY PLATFORMS
1 work email found
@lifescienceangels.com
4 phones found area 301 and 202
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer
Location
Washington DC-Baltimore Area, United States, United States
Company size
Who is Kelly M. Mcvearry? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kelly M. Mcvearry is listed as Chief Executive Officer at BENTO BIOLOGY PLATFORMS, a company with 8 employees, based in Washington DC-Baltimore Area, United States, United States. AeroLeads shows a work email signal at lifescienceangels.com, phone signal with area code 301, 202, and a matched LinkedIn profile for Kelly M. Mcvearry.
Kelly M. Mcvearry previously worked as Hypatia Group, Chairman and Managing Partner at Hypatia and Managing Director, HYPATIA VETS at Hypatia. Kelly M. Mcvearry holds Ph.D., Neuroscience from Georgetown University.
Company email context
Email format at BENTO BIOLOGY PLATFORMS
This section adds company-level context without repeating Kelly M. Mcvearry's masked contact details.
{first_initial}{last}@lifescienceangels.com
86% confidence
AeroLeads found 1 current-domain work email signal for Kelly M. Mcvearry. Compare company email patterns before reaching out.
Profile bio
About Kelly M. Mcvearry
I build platform technologies and invest in horizon technologies that improve healthspan and advance human creativity.
Listed skills include Leadership, Research, Clinical Research, Program Management, and 16 others.
Current workplace
Kelly M. Mcvearry's current company
Company context helps verify the profile and gives searchers a useful next step.
Bento Biology Platforms
23 roles
Kelly M. Mcvearry work experience
A career timeline built from the work history available for this profile.
Hypatia Group, Chairman And Managing Partner
CurrentHypatia Group seeds platform technologies to increase human healthspan, advance health equity, and enable economic prosperity (https://www.hypatiagroup.io/). We build things with creative people and invest in step-change technologies. Visit Bento Bio, our 2022 spin out...we're bringing Play to Learn (P2L) and Participate to Earn (P2E) principles to.
Dec 2017 - Present
Managing Director, Hypatia Vets
CurrentHYPATIA VETS (B2G) is a Joint Venture formed to provide mission leaders in the public sector access to end-to-end IT services (IaaS, PaaS, DaaS, ZTA, ConMon, PenTesting, 2TM, Takeback) and cutting edge solutions with emerging technologies (AIML, Quantum, AR/VR, Web3, LEO Comms). With top secret facilities and deep bench of science and engineering talent.
Jul 2022 - Present
Hypatia Project, Chief Executive Officer
Hypatia Project (B2G/B2B) is the digital skunkworks of the Hypatia Group, leading code-named technology projects as a trusted innovation partner to governments and industry. We work on ‘hard problems’ at the interface of hardware, software, biology and physics, with core capabilities architecting platform technologies and implementing digital.
Sep 2016 - Aug 2022
Ncats Advisory Council
Current
Jun 2021 - Present
Cures Acceleration Network (Can) Review Board, Nih Ncats
Current
Sep 2021 - Present
Co-Chair, Fda Public Private Partnership - Lupus Accelerating Breakthroughs Consortium
CurrentLaunched in March 2023, FDA’s Center for Drug Evaluation and Research announced a partnership with the Lupus Research Alliance (LRA) to launch the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership focused on addressing challenges impacting lupus clinical trial success (read more.
Mar 2023 - Present
Board Of Directors, Lupus Therapeutics
Current
Feb 2018 - Present
Chairman, Board Of Directors, Lupus Therapeutics
Launched the Lupus Clinical Investigators Network (LuCIN), a clinical trial implementation infrastructure comprised of 57 academic medical centers (AMDs) in the US and Canada with 200 clinical investigators and patient communities to accelerate translational science and commercialization of drugs and biologics for lupus and adjacent autoimmune disease.
Feb 2018 - Jan 2021
Executive Committee, Lupus Clinical Investigators Network (Lucin) For Clinical Trials
Nov 2015 - Jan 2018
Cofounder And Chief Executive Officer
Current
Mar 2022 - Present
Investor
Improving healthcare worldwide by helping entrepreneurs with disruptive advances in healthcare discovery and delivery (https://www.lifescienceangels.com/see-deals-we-funded).Life Science Angels (LSA) is a group of 150 accredited angel investors based in Palo Alto, CA. In August 2014, Life Science Angels was named the Top Angel Investment Group in the U.S..
Feb 2015 - Feb 2024
Board Of Directors, Chair Of Syndication, 2 Terms
I completed two terms on the LSA Board of Directors, serving as Chair of Syndication. In this role, I sourced investment opportunities, negotiated valuations and term sheets, and syndicated capital formation (Seed, A, B rounds) for new and existing LSA portfolio companies across a national network of accredited investing groups.
Mar 2016 - Mar 2020
Corporate Strategy, Health Information Systems And Dna Exploitation Portfolio
Feb 2010 - Jul 2013
Senior Scientific Advisor To The Chief Medical Officer
Jan 2009 - Jul 2013
Genomics Roundtable
Jun 2012 - Jun 2013
Neuropsychologist, Department Of Neurology
Jan 2008 - Dec 2009
Postdoctoral Research Fellow, Department Of Neurology
Sep 2007 - Dec 2009
Predoctoral Research Fellow, Department Of Neurology, Neuroscience
Jan 2002 - Oct 2007
Director
Smarthinking, Inc. > Pearson (Nyse Pso)
Launched and scaled 24/7/365 synchronous e-learning platform for Psychology business unit; created bundling alliances with textbook publishers for higher education; recruited, hired and managed global team of 18 direct reports. Acquired by Pearson (NYSE: PSO).
Jul 2000 - Jul 2002
Faculty, Neurodevelopmental Disorders, Lorenzo De’Medici
Designed and implemented diagnostic-prescriptive interventions, interactive games and individualized educational programs to enhance cognitive performance for 500+ children with neurodevelopmental disorders at the internationally acclaimed clinical day facility and arts-infused learning center founded by the legendary Sally L. Smith. Roles included.
Sep 1994 - Aug 1999
Robert Rauschenberg Foundation / Visiting Artists Training Program In Learning Disabilities
I collaborated with Robert Rauschenberg, Sally Smith, National Gallery of Art and Faculty to develop and execute curriculum, public art building, and training workshops for visiting artists serving communities with learning disabilities in tribal organizations, rural schools, and under-resourced urban centers. https://www.rauschenbergfoundation.org/
Apr 1995 - May 1999
Commercial Real Estate Portfolio Manager
The Charles E. Smith Companies > Vornado
Managed 18 direct reports and a commercial portfolio of 1.8 million square feet and 27 acres in Washington's central business district and Northern Virginia's technology corridor, completing an in-house business management administration program in finance, accounting, contract negotiation, risk management and real estate law.
Jun 1992 - Aug 1994
10 education records
Kelly M. Mcvearry education
Ph.D., Neuroscience
Georgetown University
Master'S Degree, Cognitive Psychology
Harvard University
Master'S Degree, Learning Disabilities & Psychoeducational Assessment
American University
B.A., Buckham Scholar Of English Literature
University Of Vermont
Education record
Georgetown Visitation
Postdoctoral Fellowship
Georgetown University
Postdoctoral Fellow
Georgetown University School Of Medicine
Education record
Harvard University
Education record
Harvard University
Master'S Degree, Cognitive Science
Harvard University
FAQ
Frequently asked questions about Kelly M. Mcvearry
Quick answers generated from the profile data available on this page.
What company does Kelly M. Mcvearry work for?
Kelly M. Mcvearry works for BENTO BIOLOGY PLATFORMS.
What is Kelly M. Mcvearry's role at BENTO BIOLOGY PLATFORMS?
Kelly M. Mcvearry is listed as Chief Executive Officer at BENTO BIOLOGY PLATFORMS.
What is Kelly M. Mcvearry's email address?
AeroLeads has found 1 work email signal at @lifescienceangels.com for Kelly M. Mcvearry at BENTO BIOLOGY PLATFORMS.
What is Kelly M. Mcvearry's phone number?
AeroLeads has found 4 phone signal(s) with area code 301, 202 for Kelly M. Mcvearry at BENTO BIOLOGY PLATFORMS.
Where is Kelly M. Mcvearry based?
Kelly M. Mcvearry is based in Washington DC-Baltimore Area, United States, United States while working with BENTO BIOLOGY PLATFORMS.
What companies has Kelly M. Mcvearry worked for?
Kelly M. Mcvearry has worked for Bento Biology Platforms, Hypatia, National Center For Advancing Translational Sciences (Ncats), Lupus Research Alliance, and Life Science Angels.
How can I contact Kelly M. Mcvearry?
You can use AeroLeads to view verified contact signals for Kelly M. Mcvearry at BENTO BIOLOGY PLATFORMS, including work email, phone, and LinkedIn data when available.
What schools did Kelly M. Mcvearry attend?
Kelly M. Mcvearry holds Ph.D., Neuroscience from Georgetown University.
What skills is Kelly M. Mcvearry known for?
Kelly M. Mcvearry is listed with skills including Leadership, Research, Clinical Research, Program Management, Strategic Planning, Lifesciences, Clinical Trials, and Public Health.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial